Table of Contents Table of Contents
Previous Page  82 / 244 Next Page
Information
Show Menu
Previous Page 82 / 244 Next Page
Page Background

81

INTRODUCTION

Which graft is the best for anterior cruciate

ligament (ACL) reconstruction? The literature

is replete with studies attempting to answer this

seemingly simple question, yet no definitive

conclusion has been reached. The reason for

lack of consensus is found not in the quality of

the studies attempting to answer this question,

but in the question itself. There is no “best”

ACL graft any more than there is a “best” type

of food. Each graft has its advantages and

disadvantages. Our responsibility as surgeons

and researchers is to identify and communicate

the advantages and disadvantages of each graft

to our patients to arrive at an informed decision.

Thus, the question we should be asking is

“Which graft is the best for this patient?”

The answer to this question is based on both

patient and surgeon factors. Patient physical

factors including age, activity level, height and

weight, and prior graft harvests must be

considered, along with patient preferences

regarding time to return to sport, concerns

about scar and cosmesis, and possible

complications of each graft type. Surgeon

factors including familiarity with graft harvest

and fixation techniques must also be considered.

Most importantly, these decisions should be

firmly grounded in data from the literature.

ALLOGRAFT

VERSUS

AUTOGRAFT

When narrowing down the choice of graft,

the first question is whether to utilize allograft

or autograft tissue. Autograft is the gold

standard for ACL reconstruction, while

allograft has inherent advantages and

disadvantages. On the positive side, allograft

certainly reduces harvest site morbidity and

early post-operative pain. Concerns about

allograft include disease transmission, low

availability in some countries, and increased

failure risk in certain populations. Allograft

tissue has been associated with increased

failure risk in younger, more active patient

populations [4, 9] while allograft has yielded

similar results to autograft in older patients

[11]. The MARS group similarly demonstrated

poorer outcomes in young, active patients who

underwent revision ACL reconstruction with

allograft tissue [12]. Further, when using

allograft, one must has a clear understanding of

the processing of the graft as certain sterilization

GRAFT CHOICE AND RESULTS:

WHAT DOES THE LITERATURE SAY?

R.A. MAGNUSSEN